Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Device labeling: the following is a list of potential adverse events that may occur with breast implant surgery.The risks include: implant deflation/leakage, additional surgery, capsular contracture, infection, toxic shock syndrome, necrosis, hematoma, seroma, extrusion, breast pain, changes in nipple sensation, changes in breast sensation, dissatisfaction with cosmetic results (wrinkling, folding, displacement, asymmetry, palpability, visibility, ptosis, sloshing), calcific deposits, irritation/inflammation, delayed wound healing, hypertrophic scarring, breast tissue atrophy/chest wall deformity, difficulty/inability in breast feeding, and inability to adequately visualize breast lesions with mammography.In addition to these potential adverse events, there have been concerns with certain systemic diseases.Pain- as expected following any invasive surgical procedure, pain of varying intensity and duration may occur following tissue expander placement.In addition, the expansion process may cause some discomfort, but should not cause excessive pain.Pain may indicate expansion beyond tissue tolerance, which could result in ischemia and necrosis.Pain may also accompany other adverse reactions.Unexplained pain must be promptly investigated.Further expansion should be discontinued until the pain is resolved.Excessively rapid tissue expansion may compromise the vasculature of the overlying tissue.Stop filling immediately if any signs of tissue damage, wound dehiscence, abnormal skin pallor (e.G., blanching), erythema, edema, pain, or tenderness are observed.In the absence of other signs, some temporary erythema may occur as a recognized normal tissue response to expansion.
|